Galapagos NV
GLPG
#5192
Rank
NZ$3.13 B
Marketcap
NZ$46.64
Share price
0.00%
Change (1 day)
-13.09%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): NZ-$0.93

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.69. In 2025 the company made an earnings per share (EPS) of NZ$9.62 an increase over its 2024 EPS that were of NZ$1.96.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.93-109.62%
2025NZ$9.62390.86%
2024NZ$1.96-67.16%
2023NZ$5.97-199.64%
2022NZ-$5.9999.03%
2021NZ-$3.01-68.98%
2020NZ-$9.70-298.06%
2019NZ$4.90-554.64%
2018NZ-$1.08-77.18%
2017NZ-$4.72-326.21%
2016NZ$2.09-134.19%
2015NZ-$6.11-371.34%
2014NZ$2.25-445.98%
2013NZ-$0.6532.88%
2012NZ-$0.49-82.07%
2011NZ-$2.73-817.9%
2010NZ$0.3812.73%
2009NZ$0.34-120.79%
2008NZ-$1.62-37.67%
2007NZ-$2.6039.64%
2006NZ-$1.8628.17%
2005NZ-$1.456.25%
2004NZ-$1.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.69-2,244.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.07-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.46-604.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.31-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.01-977.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.69-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.54-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ$6.04-981.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.30-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel